Acute Kidney Injury in Pediatric Acute SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children

Manpreet K Grewal1,2, Melissa J Gregory1,2, Amrish Jain1,2

  • 1Division of Nephrology and Hypertension, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, United States.

Frontiers in Pediatrics
|August 26, 2021
PubMed

Insights

Children with COVID-19 and multisystem inflammatory syndrome (MIS-C) face a high risk of acute kidney injury (AKI), especially those with MIS-C. Prompt recognition and renal protective strategies are crucial for recovery in this vulnerable pediatric group.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to significant morbidity in children.
  • Multisystem inflammatory syndrome in children (MIS-C) is a serious complication associated with SARS-CoV-2.
  • Acute kidney injury (AKI) is a potential complication in critically ill children, but its prevalence in SARS-CoV-2 and MIS-C requires further investigation.

Purpose of the Study:

  • To determine the incidence of AKI in pediatric patients diagnosed with SARS-CoV-2 infection, with or without MIS-C.
  • To identify clinical and laboratory factors associated with the development of AKI in this patient population.
  • To understand the distinct pathophysiological mechanisms of AKI in SARS-CoV-2 infection versus MIS-C.

Main Methods:

  • Retrospective chart review of 113 pediatric patients admitted with SARS-CoV-2 infection between March and August 2020.
  • Data collection included demographics, laboratory results, imaging, echocardiography, and treatment details.
  • Statistical analysis, including multivariate analysis, was performed to identify predictors of AKI.

Main Results:

  • Of 92 analyzed patients, 24% developed AKI, with 36% of those reaching stage 3 AKI.
  • AKI prevalence was significantly higher in patients with MIS-C (54%) compared to those with acute SARS-CoV-2 infection (11%).
  • Independent predictors for AKI included inotropic support, African American race, and MIS-C diagnosis. All patients recovered kidney function without requiring renal replacement therapy.

Conclusions:

  • Pediatric patients with SARS-CoV-2 infection, particularly those with MIS-C, are at substantial risk for developing AKI.
  • AKI in SARS-CoV-2 appears multifactorial, involving renal hypoperfusion and direct damage, while MIS-C related AKI is primarily pre-renal due to cardiac dysfunction and hyperinflammation.
  • Clinicians should prioritize renal protective strategies for high-risk pediatric patients with SARS-CoV-2 and MIS-C to ensure optimal kidney recovery and prevent further injury.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
184
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
332
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
312
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
97
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
82
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43